Elicio Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | 11/14/2025 | 630.92 K | $6.90 M | 0.00% | 3.93% |
| VANGUARD GROUP INC | 11/07/2025 | 473.86 K | $5.18 M | 4.23% | 2.95% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 148.08 K | $1.62 M | 100.00% | 0.92% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 129.69 K | $1.42 M | 7.33% | 0.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 120.21 K | $1.32 M | 606.14% | 0.75% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 105.00 K | $1.15 M | 0.00% | 0.65% |
| MARSHALL WACE, LLP | 11/13/2025 | 86.53 K | $946.67 K | 100.00% | 0.54% |
| NORTHERN TRUST CORP | 11/14/2025 | 53.58 K | $586.21 K | 5.07% | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 48.67 K | $532.46 K | 100.00% | 0.30% |
| BLACKROCK, INC. | 11/12/2025 | 44.20 K | $483.49 K | 1.46% | 0.28% |
| STATE STREET CORP | 11/14/2025 | 38.30 K | $419.00 K | 77.31% | 0.24% |
| 11/12/2025 | 32.00 K | $194.56 K | 100.00% | 0.20% | |
| CRESSET ASSET MANAGEMENT, LLC | 11/12/2025 | 26.93 K | $294.56 K | 100.00% | 0.17% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 22.85 K | $249.94 K | 100.00% | 0.14% |
| CITADEL ADVISORS LLC | 11/14/2025 | 21.00 K | $229.74 K | 100.00% | 0.13% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 15.00 K | $164.10 K | 0.00% | 0.09% |
| MEYER HANDELMAN CO | 10/16/2025 | 13.90 K | $152.06 K | 0.00% | 0.09% |
| CITIGROUP INC | 11/10/2025 | 10.66 K | $116.60 K | 100.00% | 0.07% |
| WILEY BROS.-AINTREE CAPITAL, LLC | 11/14/2025 | 10.00 K | $109.40 K | 0.00% | 0.06% |
| MOODY LYNN & LIEBERSON, LLC | 10/20/2025 | 10.00 K | $109.40 K | 0.00% | 0.06% |
| MAYFLOWER FINANCIAL ADVISORS, LLC | 10/17/2025 | 10.00 K | $109.40 K | 0.00% | 0.06% |
| UBS GROUP AG | 11/13/2025 | 7.02 K | $76.79 K | 16.54% | 0.04% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/24/2025 | 7.00 K | $42.56 K | 0.00% | 0.04% |
| CM MANAGEMENT, LLC | 11/13/2025 | 6.00 K | $65.64 K | -76.00% | 0.04% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 5.20 K | $56.89 K | 100.00% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 3.59 K | $39.22 K | 186.80% | 0.02% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/12/2025 | 1.55 K | $17.00 K | 0.00% | 0.01% |
| MORGAN STANLEY | 11/14/2025 | 1.54 K | $16.80 K | 304.21% | 0.01% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 640 | $7.00 K | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 200 | $2.19 K | 100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 103 | $1.00 K | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 82 | $897 | -1.20% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| QUANTINNO CAPITAL MANAGEMENT LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Elicio Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 33 institutional investors and hedge funds held shares of Elicio Therapeutics, Inc.. The most heavily invested institutionals were:
Knoll Capital Management, LLC: 630,915
VANGUARD GROUP INC: 473,859
BALYASNY ASSET MANAGEMENT L.P.: 148,076
GEODE CAPITAL MANAGEMENT, LLC: 129,686
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 120,207
MARSHALL WACE, LLP: 86,533
12.10% of Elicio Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.98 M shares in the last 24 months. This purchase volume represents approximately $21.86 M in transactions.